Joanne Bryce

Joanne Bryce serves as the Interim Chief Financial Officer at SiteOne Therapeutics, Inc. since March 2024, where participation in the $1 billion acquisition negotiations by Eli Lilly and management of finance and human resources operations are key responsibilities. Prior to this role, Joanne was the Chief Financial Officer at Disc Medicine from September 2021 to February 2024, leading a successful reverse merger with Gemini Therapeutics and raising over $500 million through various financing methods. Between October 2014 and September 2021, Joanne provided contract CFO services to multiple technology and life sciences companies, and earlier experience includes serving as Chief Financial Officer at WiTricity Corporation, where Joanne oversaw significant revenue growth and funding, and as VP Finance/Interim CFO at Jingle Networks, Inc. Joanne's educational background includes a BS in Accounting from Babson College, completed in January 1988.